Design, synthesis, and molecular docking of novel indole scaffold‐based VEGFR‐2 inhibitors as targeted anticancer agents

Publisher: John Wiley & Sons Inc

E-ISSN: 1521-4184|351|2|ardp.201700299-ardp.201700299

ISSN: 0365-6233

Source: ARCHIV DER PHARMAZIE (ELECTRONIC), Vol.351, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract